Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zelira Therapeutics ( (AU:ZLD) ) has issued an announcement.
Zelira Therapeutics Limited announced a proposed issue of 550,000 ordinary fully paid securities, with the issue date set for March 31, 2025. This move is part of the company’s strategic efforts to enhance its financial position and support its ongoing projects, potentially impacting its market presence and stakeholder interests positively.
More about Zelira Therapeutics
Zelira Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of cannabinoid-based medicines. The company is involved in creating therapeutic solutions for various medical conditions, leveraging its expertise in cannabinoid research and product development.
YTD Price Performance: -22.34%
Average Trading Volume: 380
Technical Sentiment Signal: Buy
Current Market Cap: $3.43M
For detailed information about ZLD stock, go to TipRanks’ Stock Analysis page.